GEn1E Lifesciences Adds NextGen Selective Immunomodulator Target to Portfolio, Broadens Pipeline

/PRNewswire/ -- GEn1E Lifesciences, a next-generation multitarget techbio company developing novel and targeted immunomodulators, has secured an exclusive,...

Related Keywords

Baltimore ,Maryland ,United States ,University Of Maryland ,Mountain View ,Prnewswire Gen ,Paul Shapiro ,Phil Robilotto ,University Of Maryland School Pharmacy ,University Of Maryland Ventures ,Extracellular Signal Regulated Kinase ,Maryland School ,Ritu Lal ,Palo Alto ,Maryland Ventures ,